BioWorld - Saturday, March 28, 2026

BioWorld Science

Feb. 16, 2022

View Archived Issues

New DNA-dependent protein kinase inhibitors divulged by Shouyao Holdings

Read More

Vasopressin V1A receptor antagonists discovered at Roche

Read More

Medshine Discovery identifies SOS1/Gly12Cys mutant GTPase KRAS interaction inhibitors

Read More

Betta Pharmaceuticals describes new PTPN11 inhibitors

Read More

Merck KGaA, Cancer Research Technology present YAP1/TEAD interaction inhibitors

Read More

Akouos presents preclinical data on anti-VEGF AAVAnc80 vector for vestibular schwannoma

Read More

ADAM8 drives severity in acute respiratory distress syndrome trough neutrophil migration

Read More

Increasing catalase activity reverses estrogen-mediated aging

Read More

Aquinnah and Roche collaborate in ALS and neurodegenerative diseases

Read More

Alamar and SciNeuro to discover and develop novel therapeutic antibodies for neurological diseases

Read More

NTS-104 reduces critical neuroinflammatory signaling in rat embolic stroke model

Read More

Persistent Ebolavirus in brain seeds relapses

Read More

NIBIOHN and Shionogi announce discovery of novel antiviral antibody for SARS-CoV-2

Read More

Memo Therapeutics to advance lead programs

Read More

YTHDF1 is involved in renal fibrosis through upregulation of YAP

Read More

Financing at Third Harmonic Bio to support development of oral KIT inhibitor THB-001

Read More